Urofollitropin
≥200 IU/mg
- Product Code: 78034
CAS:
97048-13-0
| Molecular Weight: | 980.16 g./mol | Molecular Formula: | C₄₂H₆₅N₁₁O₁₂S₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
Urofollitropin is primarily used in fertility treatments to stimulate ovarian follicular growth in women who have difficulty conceiving due to ovulatory disorders. It is often administered as part of assisted reproductive technologies, such as in vitro fertilization (IVF), to promote the development of multiple follicles, thereby increasing the chances of successful egg retrieval. Additionally, it is used in combination with other hormones, like human chorionic gonadotropin (hCG), to trigger ovulation. In men, urofollitropin can be employed to treat hypogonadotropic hypogonadism, a condition characterized by low testosterone levels, by stimulating spermatogenesis. Its application is carefully monitored through hormonal assays and ultrasounds to ensure optimal dosing and minimize risks such as ovarian hyperstimulation syndrome (OHSS).
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 1.000 | 10-20 days | €236.96 |
+
-
|
| 5.000 | 10-20 days | €987.74 |
+
-
|
Urofollitropin
Urofollitropin is primarily used in fertility treatments to stimulate ovarian follicular growth in women who have difficulty conceiving due to ovulatory disorders. It is often administered as part of assisted reproductive technologies, such as in vitro fertilization (IVF), to promote the development of multiple follicles, thereby increasing the chances of successful egg retrieval. Additionally, it is used in combination with other hormones, like human chorionic gonadotropin (hCG), to trigger ovulation. In men, urofollitropin can be employed to treat hypogonadotropic hypogonadism, a condition characterized by low testosterone levels, by stimulating spermatogenesis. Its application is carefully monitored through hormonal assays and ultrasounds to ensure optimal dosing and minimize risks such as ovarian hyperstimulation syndrome (OHSS).
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
€0.00
€0.00
Total :